TIAA Trust, National Association
GILD icon

TIAA Trust, National Association’s Gilead Sciences GILD Stock Holding History

TIAA Trust, National Association’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$642K Sell
5,082
-174
-3% -$22.9K 0.04% 131
2026
Q1 		$733K Sell
5,256
-24,292
-82% -$3.4M 0.04% 148
2025
Q4 		$3.63M Buy
29,548
+5,050
+21% +$614K 0.01% 258
2025
Q3 		$2.72M Sell
24,498
-62
-0.3% -$7.05K 0.01% 282
2025
Q2 		$2.72M Buy
24,560
+109
+0.4% +$11.6K 0.01% 272
2025
Q1 		$2.74M Sell
24,451
-110
-0.4% -$11.3K 0.01% 264
2024
Q4 		$2.27M Sell
24,561
-479
-2% -$43.1K 0.01% 284
2024
Q3 		$2.1M Buy
25,040
+470
+2% +$35.9K 0.01% 294
2024
Q2 		$1.69M Sell
24,570
-5,242
-18% -$350K 0.01% 293
2024
Q1 		$2.18M Sell
29,812
-5,352
-15% -$412K 0.01% 275
2023
Q4 		$2.85M Sell
35,164
-1,574
-4% -$122K 0.01% 244
2023
Q3 		$2.75M Buy
+36,738
New +$2.83M 0.01% 240

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

TIAA Trust, National Association's GILD Position: Q2 2026 in Review

TIAA Trust, National Association reduced its Gilead Sciences (GILD) stake by 3.3% in Q2 2026, selling an estimated $22.9K and leaving 5,082 shares worth $642K. The position accounts for 0.04% of the portfolio, ranked #131.

TIAA Trust, National Association first reported a position in GILD in Q3 2023 and has held it in 12 quarters since. The position peaked at $3.63M in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • TIAA Trust, National Association held 5,082 shares of Gilead Sciences worth $642K as of Q2 2026.
  • TIAA Trust, National Association sold 174 Gilead Sciences shares in Q2 2026, an estimated $22.9K.
  • Gilead Sciences made up 0.04% of TIAA Trust, National Association's portfolio in Q2 2026, its #131 holding.
  • TIAA Trust, National Association first reported a position in Gilead Sciences in Q3 2023 and has held it in 12 quarters since.
  • TIAA Trust, National Association's Gilead Sciences position peaked at $3.63M in Q4 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on TIAA Trust, National Association's 13F filing for Q2 2026, filed 10 Aug 2026.